Keyphrases
Body Composition
100%
Expenditure Composition
100%
Obese Men
100%
Energy Expenditure
100%
β3-adrenergic Receptor Agonist
100%
Placebo
40%
Between-group
40%
Triacylglycerol
40%
Randomized Controlled Trial
20%
Treatment Group
20%
Copenhagen
20%
Denmark
20%
Royal
20%
Mediating Effect
20%
Highly Selective
20%
Obesity
20%
Body Mass Index
20%
Dietary Intervention
20%
Non-diabetic
20%
Group Studies
20%
Non-smoking
20%
Multicenter Randomized Controlled Trial
20%
Energy Balance
20%
Weight Maintenance
20%
Fat Mass
20%
Substrate Oxidation
20%
Glucose Tolerance
20%
Lipolysis
20%
Receptor-mediated
20%
Human nutrition
20%
Veterinary
20%
Chronic Effects
20%
Research Department
20%
β3 Adrenergic Receptor
20%
Publication Type
20%
Thermogenic
20%
Agricultural University
20%
Thermogenic Activity
20%
Non-protein Respiratory Quotient
20%
β-adrenergic Agonist
20%
Placebo Groups
20%
Treatment Change
20%
Beta-3 Adrenergic Agonist
20%
INIS
receptors
100%
men
100%
body composition
100%
energy consumption
100%
adrenergics
100%
humans
60%
concentration
60%
weight
40%
glucose
20%
tissues
20%
nutrition
20%
regulations
20%
comparative evaluations
20%
stimulation
20%
clinical trials
20%
design
20%
interventions
20%
fats
20%
universities
20%
tolerance
20%
denmark
20%
substrates
20%
obesity
20%
plasma
20%
oxidation
20%
maintenance
20%
energy balance
20%
Agricultural and Biological Sciences
Beta-3 Adrenergic Receptor
100%
Placebo
100%
Agonist
100%
Body Composition
100%
Triglyceride
66%
Publications
33%
Body Mass Index
33%
Human Nutrition
33%
Respiratory Quotient
33%
Glucose Tolerance
33%
Beta-Adrenergic Agonist
33%
Blood Plasma
33%
Biochemistry, Genetics and Molecular Biology
Body Composition
100%
Energy Expenditure
100%
Beta-3 Adrenergic Receptor
100%
Receptor Agonists
100%
Triglyceride
40%
Fat Mass
20%
Downregulation
20%
Agonist
20%
Randomized Controlled Trial
20%
Body Mass
20%
Beta-Adrenergic Agonist
20%
Clinical Trial
20%
Energy Balance
20%
Respiratory Quotient
20%
Blood Plasma
20%
Neuroscience
Energy Expenditure
100%
Beta-3 Adrenergic Receptor
100%
Sympathomimetic Drug
100%
Placebo
60%
Triacylglycerol
40%
Randomized Controlled Trial
20%
Body Mass Index
20%
Energy Balance
20%
Beta-Adrenergic Agonist
20%
Respiratory Quotient
20%
Blood Plasma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Beta 3 Adrenergic Receptor Stimulating Agent
100%
Triacylglycerol
66%
Randomized Controlled Trial
33%
Beta Adrenergic Receptor Stimulating Agent
33%
Clinical Trial
33%
Beta 3 Adrenergic Receptor
33%
Food Science
Energy Balance
100%
Human Nutrition
100%